BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ochalek J, Wang H, Gu Y, Lomas J, Cutler H, Jin C. Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach. Pharmacoeconomics 2020;38:1319-31. [PMID: 32856280 DOI: 10.1007/s40273-020-00954-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen K, Zhong Y, Gu Y, Sharma R, Li M, Zhou J, Wu Y, Gao Y, Qin G. Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model. JAMA Netw Open 2020;3:e2023949. [PMID: 33275150 DOI: 10.1001/jamanetworkopen.2020.23949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ochalek J, Abbas K, Claxton K, Jit M, Lomas J. Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries. BMJ Glob Health 2020;5:e003006. [PMID: 33082132 DOI: 10.1136/bmjgh-2020-003006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Liu D, Leung K, Jit M, Wu JT. Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities. Vaccine 2021;39:5490-8. [PMID: 34454783 DOI: 10.1016/j.vaccine.2021.08.057] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hu W, Xu W, Si L, Wang C, Jiang Q, Wang L, Cutler H. Cost-effectiveness of the Da Qing diabetes prevention program: A modelling study. PLoS One 2020;15:e0242962. [PMID: 33382746 DOI: 10.1371/journal.pone.0242962] [Reference Citation Analysis]
5 Chi YL, Blecher M, Chalkidou K, Culyer A, Claxton K, Edoka I, Glassman A, Kreif N, Jones I, Mirelman AJ, Nadjib M, Morton A, Norheim OF, Ochalek J, Prinja S, Ruiz F, Teerawattananon Y, Vassall A, Winch A. What next after GDP-based cost-effectiveness thresholds? Gates Open Res 2020;4:176. [PMID: 33575544 DOI: 10.12688/gatesopenres.13201.1] [Reference Citation Analysis]
6 Lomas J, Claxton K, Ochalek J. Accounting for Country- and Time-Specific Values in the Economic Evaluation of Health-Related Projects Relevant to low- and Middle-Income Countries. Health Policy Plan 2021:czab104. [PMID: 34410385 DOI: 10.1093/heapol/czab104] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]